You are here

Alzheimer's disease guidelines are 'inadequate'

Alzheimer's disease guidelines are 'inadequate'
10th March 2009

Guidelines which are issued by the National Institute of Clinical Excellence (Nice) concerning the prescription of drugs to those suffering from Alzheimer's disease are inadequate, it is said.

Recent research from the University of Hull found that many sufferers in the early stages of the condition could have an "excellent response" to prescribed cholinesterase drugs.

This is despite Nice's guidelines specifying that only those experiencing a more severe affectation from the disease should receive such a treatment.

In the study, 26 patients were studied over a five-month period, with brain activity measured throughout.

Commenting on the findings, professor Annalena Venneri said: "The research stresses the need to identify responders at the early stages of the disease by accurate assessment of patients' deficits and stabilise their symptoms, giving patients a better quality of life for a longer time."

According to a study for the American Academy of Neurology last month, people who watch less than seven hours of TV a day are 50 per cent less likely to develop a condition which includes memory loss.

Please click here for advice to help you find the right type of care.